In Vivo Imaging of Brain Dopaminergic Neurotransmission System in Small Animals with High-resolution Singles Photon Emission Computed Tomography

Access this Article

Author(s)

Abstract

High-resolution single photon emission computed tomography (SPECT) provides a unique capability to image the biodistribution of radiolabeled molecules in small laboratory animals. Thus, we applied the high-resolution SPECT to <I>in vivo</I> imaging of the brain dopaminergic neurotransmission system in common marmosets using two radiolabeled ligands, [<SUP>123</SUP>I]2β-carbomethoxy-3β-(4-iodophenyl)tropane (β-CIT) as a dopamine transporter (DAT) ligand and [<SUP>123</SUP>I]iodobenzamide (IBZM) as a dopamine D<SUB>2</SUB> receptor (D<SUB>2</SUB>R) ligand. Specific images of the striatum, a region with a high density of dopaminergic synapses, were obtained at 240 min and 60 min after injection of [<SUP>123</SUP>I]β-CIT and [<SUP>123</SUP>I]IBZM, respectively. Furthermore, a significantly low accumulation of [<SUP>123</SUP>I]β-CIT in the striatum was observed in MPTP-treated animals compared with results for a control group, and a similar accumulation in the control group was observed with the pretreatment of deprenyl in the MPTP-treated animals. However, the striatal accumulation of [<SUP>123</SUP>I]IBZM showed no changes among the control, MPTP-treated, and deprenyl-MPTP-treated groups. These SPECT imaging results agreed well with those of DA concentration and motor behavior. Since MPTP destroys nigrostriatal dopamine nerves and produces irreversible neurodegeneration associated with Parkinsonian syndrome, SPECT imaging data in this study demonstrated that deprenyl shows its neuroprotective effect on Parkinsonism by protecting against the destruction of presynaptic dopamine neurons.

Journal

  • Analytical Sciences

    Analytical Sciences 19(1), 67-71, 2003-01-10

    The Japan Society for Analytical Chemistry

References:  25

  • <no title>

    TONAMI N.

    A New Textbook of Clinical Nuclear Medicine, 2001

    Cited by (1)

  • <no title>

    YANAI K.

    Br. J. Pharmacol. 116, 1649, 1995

    Cited by (1)

  • <no title>

    HUME S. P.

    J. Neurosci. Meth. 76, 45, 1997

    Cited by (1)

  • <no title>

    PHELPS M. E.

    Proc. Natl. Acad. Sci. USA 97, 9226, 2000

    Cited by (1)

  • <no title>

    PHELPS M. E.

    J. Nucl. Med. 41, 661, 2000

    Cited by (1)

  • <no title>

    MYERS R.

    Nucl. Med. Biol. 28, 585, 2001

    Cited by (1)

  • <no title>

    CHATZIIOANNOU A. F.

    Eur. J. Nucl. Med. 29, 98, 2002

    Cited by (1)

  • <no title>

    CHATZIIOANNOU A. F.

    J. Nucl. Med. 40, 1164, 1999

    Cited by (1)

  • <no title>

    TORNAI M. P.

    J. Nucl. Med. 40, 1176, 1999

    Cited by (1)

  • <no title>

    NIKOLAUS S.

    J. Nucl. Med. 42, 1691, 2001

    Cited by (1)

  • <no title>

    ISHIZU K.

    J. Nucl. Med. 36, 2282, 1995

    Cited by (1)

  • <no title>

    MARKEY S. P.

    Nature 311, 464, 1984

    Cited by (2)

  • <no title>

    MONOTO M.

    Eur. J. Pharmacol. 121, 123, 1986

    Cited by (1)

  • <no title>

    TATTON W. G.

    J. Neurosci. Res. 30, 666, 1991

    Cited by (1)

  • <no title>

    EDADI M.

    J. Neurosci. Res. 67, 285, 2002

    Cited by (1)

  • <no title>

    ZEA-PONCE Y.

    J. Nucl. Med. 36, 525, 1995

    Cited by (1)

  • <no title>

    KUNG M. P.

    J. Labelled Compd. Radipharm. 27, 691, 1989

    Cited by (1)

  • <no title>

    NOMOTO M.

    Neuropharmacol. 32, 473, 1993

    Cited by (1)

  • <no title>

    IRIFUNE M.

    Eur. J PharmacoL 238, 235, 1993

    Cited by (2)

  • <no title>

    ASENBAUM S.

    J. Nucl. Med. 38, 1, 1997

    Cited by (1)

  • <no title>

    ANAND A.

    Am. J. Psychiatry 157, 1108, 2000

    Cited by (1)

  • <no title>

    BRUCKE T.

    J. Neural. Transm. Gen. Sect. 94, 137, 1993

    Cited by (1)

  • <no title>

    PALACIOS J. M.

    J. Neural. Transm. Suppl. 27, 227, 1988

    Cited by (1)

  • <no title>

    DE KEYSER J.

    J. Neurochem. 53, 1400, 1989

    Cited by (1)

  • <no title>

    SZIRAKI I.

    Progress in Brain Research 106, 155, 1995

    Cited by (1)

Codes

  • NII Article ID (NAID)
    10011102842
  • NII NACSIS-CAT ID (NCID)
    AA10500785
  • Text Lang
    ENG
  • Article Type
    ART
  • ISSN
    09106340
  • NDL Article ID
    6408884
  • NDL Source Classification
    ZP4(科学技術--化学・化学工業--分析化学)
  • NDL Call No.
    Z54-F482
  • Data Source
    CJP  NDL  J-STAGE 
Page Top